[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337919-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337919-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","ubqln4-promotes-the-proliferation-and-invasion-of-non-small-cell-lung-cancer-cell-by-regulating-pi3kakt-pathway","UBQLN4 promotes the proliferation and invasion of non-small cell lung cancer cell by regulating PI3K/AKT pathway","","Ubiquilin-4 (UBQLN4) is addressed as a previously underexplored regulator in non-small cell lung cancer (NSCLC). Using TCGA data and experimental assays, the study evaluates UBQLN4 expression in NSCLC cells and tissues, relates it to patient prognosis via Kaplan–Meier analysis, and quantifies functional effects on proliferation and invasion through CCK-8, colony formation, and transwell tests. Signaling changes are examined by path scan intracellular arrays, with in vivo tumorigenesis supporting a mechanistic link to PI3K/AKT.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/ubqln4-promotes-the-proliferation-and-invasion-of-non-small-cell-lung-cancer-cell-by-regulating-pi3kakt-pathway/337919/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/ubqln4-promotes-the-proliferation-and-invasion-of-non-small-cell-lung-cancer-cell-by-regulating-pi3kakt-pathway/337919.png","ImageObject",300,407,{"name":42,"@type":43},"Aria","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does UBQLN4 play in NSCLC according to the study?","Question",{"text":63,"@type":64},"UBQLN4 promotes NSCLC cell proliferation and invasion by activating the PI3K/AKT pathway.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was UBQLN4 validated as differentially expressed in NSCLC?",{"text":68,"@type":64},"The Cancer Genome Atlas (TCGA) was used to identify UBQLN4 as differentially expressed, followed by immunohistochemistry and western blotting to assess expression in NSCLC cells and tissues.",{"name":70,"@type":61,"acceptedAnswer":71},"Which experiments linked UBQLN4 to PI3K/AKT signaling and disease progression?",{"text":72,"@type":64},"Path scan intracellular signaling array results implicated PI3K/AKT, which was further supported by in vitro and in vivo tumorigenesis findings, alongside functional loss and gain analyses.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337919,1790591015,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":112,"preview_page_count":33,"preview_urls":145},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Journal of Cancer Research and Clinical Oncology (2024) 150:335  \n[https://doi.org/10.1007/s00432-024-05862-8](https://doi.org/10.1007/s00432-024-05862-8)  \nRESEARCH  \nUBQLN4 promotes the proliferation and invasion of non-small cell lung cancer cell by regulating PI3K/AKT pathway  \nLi He1 · Heng Chen2 · Bin Ruan2 · Li He3 · Ming Luo2 · Yulun Fu2 · Rui Zou2  \nReceived: 6 May 2024 / Accepted: 19 June 2024 / Published online: 6 July 2024 © The Author(s) 2024  \nAbstract  \nBackground Ubiquilin-4 (UBQLN4), a member of the ubiquilin family, has received limited attention in cancer research to date. Here, we investigated for the first time the functional role and mechanism of UBQLN4 in non-small cell lung cancer (NSCLC) .  \nMethods The Cancer Genome Atlas (TCGA) database was employed to validate UBQLN4 as a differentially expressed gene. Expression differences of UBQLN4 in NSCLC cells and tissues were assessed using immunohistochemistry (IHC) experiment and western blotting (WB) experiment. Kaplan-Meier analysis was conducted to examine the association between UBQLN4 expression and NSCLC prognosis. Functional analyses of UBQLN4 were performed through cell counting kit-8 (CCK-8), colony formation, and transwell invasion assays. The impact of UBQLN4 on tumor-associated signaling pathways was assessed using the path scan intracellular signaling array. In vivo tumorigenesis experiments were conducted to further investigate the influence of UBQLN4 on tumor formation.  \nResults UBQLN4 exhibited up-regulation in both NSCLC tissues and cells. Additionally, over-expression of UBQLN4 was associated with an unfavorable prognosis in NSCLC patients. Functional loss analyses demonstrated that inhibiting UBQLN4 could suppress the proliferation and invasion of NSCLC cells in both in vitro and in vivo settings. Conversely, functional gain experiments yielded opposite results. Path scan intracellular signaling array results suggested that the role of UBQLN4 is associated with the PI3K/AKT pathway, a correlation substantiated by in vitro and in vivo tumorigenesis experiments.  \nConclusion We validated that UBQLN4 promotes proliferation and invasion of NSCLC cells by activating the PI3K/AKT pathway, thereby facilitating the progression of NSCLC. These findings underscore the potential of targeting UBQLN4 as a therapeutic strategy for NSCLC.  \nKeywords Ubiquilin-4 (UBQLN4) · Non–small cell lung cancer (NSCLC) · Proliferation · Invasion · PI3K/AKT pathway  \nAbbreviations  \n􀀍 Rui Zou[sjyzr12345678@163.com](sjyzr12345678@163.com)  \n1 Department of Oncology, The People’s Hospital of Xinyu City, Xinyu, Jiangxi 338099, People’s Republic of China  \n2 Department of Oncology, The First Affiliated Hospital, Jiangxi Medical Collge, Nanchang University, 17 Yongwai Street, Nanchang, Jiangxi 330006, People’s Republic of China  \n3 Department of Pathology, Jingdezhen First People’s Hospital, Jingdezhen, Jiangxi 333000, People’s Republic of China  \nUBQLN4 NSCLCLUSC  \nLUADUBQLN TCGA  \nHCC  \nIHC  \nWB  \nCCK-8  \nDMEM  \nRNA  \nPBS  \nUbiquilin-4  \nNon small cell lung cancer Lung squamous cell carcinoma  \nLung adenocarcinoma Ubiquilin protein The Cancer Genome Atlas Hepatocellular carcinoma Immunohistochemistry Western blotting  \nCell counting kit-8  \nDulbecco’s modified eagle’s medium Ribonucleic acid  \nPhosphate buffer saline  \nmRNA  \nEMT  \nqRT-PCR  \nGSK-3β  \nMessenger RNA  \nEpithelial-mesenchymal transition Quantitative reverse transcription polymerase chain reaction  \nGlycogen synthase kinase-3β  \nIntroduction  \nLung cancer is a prevalent malignant tumor posing a significant threat to human life. It ranks second in global cancer incidence, trailing only behind breast cancer in women, and holds the top position in global cancer-related mortality, serving as a primary cause of cancer deaths worldwide(Mederos et al. 2020; Xie et al. 2021) . Based on histopathological characteristics, lung cancer is primarily categorized into non-small cell lung cancer (NSCLC) and small cell lung","cbCaifq7VKVu6DXp","https://ap.wps.com/l/cbCaifq7VKVu6DXp","pdf",2042146,12,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Keywords\n# Abbreviations\n# Introduction","[{\"question\":\"What role does UBQLN4 play in NSCLC according to the study?\",\"answer\":\"UBQLN4 promotes NSCLC cell proliferation and invasion by activating the PI3K/AKT pathway.\"},{\"question\":\"How was UBQLN4 validated as differentially expressed in NSCLC?\",\"answer\":\"The Cancer Genome Atlas (TCGA) was used to identify UBQLN4 as differentially expressed, followed by immunohistochemistry and western blotting to assess expression in NSCLC cells and tissues.\"},{\"question\":\"Which experiments linked UBQLN4 to PI3K/AKT signaling and disease progression?\",\"answer\":\"Path scan intracellular signaling array results implicated PI3K/AKT, which was further supported by in vitro and in vivo tumorigenesis findings, alongside functional loss and gain analyses.\"}]","UBQLN4 promotes the proliferation and invasion of non-small cell lung cancer cell by regulating PI3K/AKT pathway | PDF",1790021173,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5c9a4d6f5cf05fa1a1bf35ab9af31d64.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4d66a328248eada1a27df68cd293e4d7.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b3a1b3d241fbb3513e849ac6692a8163.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7b086417ab2f10f35f036d9d50fd86de.webp",980,1301]